Colgate-Palmolive Company (CL) Shares Sold by Rhumbline Advisers

Share

Colgate-Palmolive Company (NYSE:CL) has seen its stock price gain, or, so far in 2017. SunTrust Banks also issued estimates for Colgate-Palmolive's Q3 2018 earnings at $0.81 EPS, Q4 2018 earnings at $0.84 EPS, FY2018 earnings at $3.15 EPS and FY2019 earnings at $3.48 EPS.

Checking in on the numbers for Colgate-Palmolive Company (CL), we have recently seen that the +DI is higher than the -DI. Finally, Citigroup Inc reaffirmed a "neutral" rating and set a $76.00 price objective (up from $75.00) on shares of Colgate-Palmolive Company in a research report on Friday, April 7th.

The average Wall Street analyst rating for Colgate-Palmolive Company is Hold, according to the average of 13 analyst scores. The stock of Colgate-Palmolive Company (NYSE:CL) earned "Hold" rating by Jefferies on Friday, July 21. Jefferies maintained the shares of CL in report on Thursday, July 6 with "Hold" rating. One research analyst has rated the stock with a sell rating, thirteen have assigned a hold rating and five have assigned a buy rating to the company's stock. The brokerage now has a $74.00 target price on the stock.

Shares of Colgate-Palmolive (NYSE CL) traded up 0.58% during midday trading on Wednesday, reaching $75.16. The stock decreased 0.69% or $0.8 during the last trading session, reaching $115.45. Of those insider trades, 692 shares of Colgate-Palmolive Company were purchased and 817,723 shares were sold. The stock has a market capitalization of $66.64 billion, a P/E ratio of 27.23 and a beta of 0.70.

Colgate-Palmolive Co. (CL) now has a Return on Assets (ROA) value of 19.3 Percent.

An earnings forecast is an analyst's outlook for a company's future quarterly or annual earnings. The firm had revenue of $3.83 billion during the quarter, compared to analyst estimates of $3.89 billion. Colgate-Palmolive Company had a return on equity of 4,897.09% and a net margin of 16.06%. Ameritas Investment Partners stated it has 0.08% of its portfolio in Colgate-Palmolive Company (NYSE:CL). During the same period previous year, the firm earned $0.63 earnings per share. Equities analysts forecast that Colgate-Palmolive Company will post $2.89 earnings per share for the current fiscal year.

Pakistan violates ceasefire in J&K's Poonch, third provocation in 24 hours
Pakistani troops have opened fire over 600 times till September 30, a Home Ministry official had said. Pakistan has violated ceasefire in KG Sector in Jammu and Kashmir's Poonch, according to ANI report.

TRADEMARK VIOLATION WARNING: "Colgate-Palmolive Company (CL) Given "Hold" Rating at Royal Bank Of Canada" was originally published by BBNS and is owned by of BBNS. If you are accessing this piece on another website, it was copied illegally and reposted in violation of USA and global trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.dispatchtribunal.com/2017/10/13/colgate-palmolive-company-cl-shares-sold-by-rhumbline-advisers.html.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, November 15th. Investors of record on Monday, October 23rd will be issued a $0.40 dividend.

According to the Recommendation Trends of the stock polled by Finviz, the company has a consensus recommendation of 2.8 out of the scale from 1 to 5 where 1 stands for Buy and 5 means Sell. The ex-dividend date of this dividend is Friday, October 20th. Colgate-Palmolive's payout ratio is 59.48%. Cullinan Associates Inc sold 102,167 shares as the company's stock rose 3.95% with the market. The shares were sold at an average price of $72.47, for a total transaction of $579,760.00. Following the completion of the transaction, the insider now directly owns 53,022 shares of the company's stock, valued at approximately $3,839,323.02. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.

In related news, insider Patricia Verduin sold 3,833 shares of the firm's stock in a transaction that occurred on Monday, July 17th.

Taking a peek at some Moving Averages, the 200-day is at 71.95, and the 50-day is 71.91. Following the completion of the transaction, the insider now directly owns 53,022 shares in the company, valued at $3,908,781.84. The disclosure for this sale can be found here. Grimes & Company Inc sold 20,328 shares as Novo Nordisk A/S (Adr) (NVO)'s stock rose 15.20%.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Principal Financial Group Inc. raised its stake in Colgate-Palmolive by 0.6% in the first quarter. The Jane Street Group Llc holds 32,200 shares with $2.39 million value, down from 95,200 last quarter. Great West Life Assurance Can holds 691,866 shares or 0.14% of its portfolio. Principal Financial Group Inc. now owns 1,271,008 shares of the company's stock valued at $93,025,000 after buying an additional 7,905 shares during the last quarter. Finally, Schaper Benz & Wise Investment Counsel Inc. Janney Montgomery Scott LLC boosted its position in Colgate-Palmolive Company by 5.4% in the first quarter. The fund owned 1,654,225 shares of the company's stock after selling 12,319 shares during the quarter. Stearns Fincl Service Grp stated it has 0.12% in Colgate-Palmolive Company (NYSE:CL). The Firm operates in two product divisions: Oral, Personal and Home Care, and Pet Nutrition.

Share